NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,577,804 | -11.6% | 103,846 | -12.5% | 0.96% | +2.3% |
| Q2 2023 | $11,970,615 | -10.1% | 118,627 | -18.0% | 0.94% | -11.9% |
| Q1 2023 | $13,314,558 | -12.1% | 144,723 | -13.3% | 1.06% | -13.7% |
| Q4 2022 | $15,147,467 | +9.2% | 166,969 | -8.5% | 1.23% | -0.9% |
| Q3 2022 | $13,871,000 | -11.1% | 182,496 | -1.1% | 1.24% | -6.0% |
| Q2 2022 | $15,599,000 | -5.0% | 184,549 | -1.4% | 1.32% | +4.0% |
| Q1 2022 | $16,417,000 | +1.5% | 187,092 | +1.2% | 1.27% | +0.1% |
| Q4 2021 | $16,175,000 | +13.7% | 184,926 | +6.3% | 1.27% | +2.7% |
| Q3 2021 | $14,223,000 | -7.3% | 173,926 | +3.5% | 1.24% | -6.0% |
| Q2 2021 | $15,338,000 | +9.6% | 168,114 | +2.7% | 1.32% | +3.9% |
| Q1 2021 | $13,990,000 | -9.2% | 163,670 | +0.3% | 1.27% | -18.1% |
| Q4 2020 | $15,404,000 | +8.2% | 163,130 | -0.3% | 1.55% | 0.0% |
| Q3 2020 | $14,232,000 | -0.9% | 163,665 | -0.4% | 1.55% | -6.2% |
| Q2 2020 | $14,359,000 | +5.1% | 164,399 | -0.8% | 1.65% | -3.2% |
| Q1 2020 | $13,667,000 | -12.3% | 165,770 | +0.7% | 1.71% | +2.0% |
| Q4 2019 | $15,591,000 | +9.4% | 164,663 | +0.4% | 1.67% | +7.2% |
| Q3 2019 | $14,245,000 | -3.1% | 163,930 | +1.8% | 1.56% | -2.1% |
| Q2 2019 | $14,700,000 | -4.2% | 160,999 | +0.9% | 1.59% | -10.2% |
| Q1 2019 | $15,338,000 | +12.2% | 159,547 | +0.2% | 1.78% | +5.6% |
| Q4 2018 | $13,665,000 | -0.7% | 159,251 | -0.3% | 1.68% | +3.0% |
| Q3 2018 | $13,755,000 | +16.5% | 159,655 | +2.1% | 1.63% | +11.6% |
| Q2 2018 | $11,808,000 | -4.4% | 156,319 | +2.3% | 1.46% | -5.3% |
| Q1 2018 | $12,351,000 | -3.2% | 152,776 | +0.5% | 1.54% | +1.0% |
| Q4 2017 | $12,757,000 | -1.7% | 151,948 | +0.5% | 1.53% | -9.0% |
| Q3 2017 | $12,978,000 | +13.7% | 151,179 | +10.6% | 1.68% | +3.6% |
| Q2 2017 | $11,413,000 | +22.6% | 136,742 | +9.1% | 1.62% | +16.5% |
| Q1 2017 | $9,309,000 | +27.9% | 125,352 | +25.5% | 1.39% | +23.8% |
| Q4 2016 | $7,276,000 | +8.2% | 99,891 | +17.7% | 1.12% | +2.4% |
| Q3 2016 | $6,726,000 | +9.2% | 84,882 | +13.6% | 1.10% | +11.5% |
| Q2 2016 | $6,162,000 | +76.9% | 74,692 | +55.3% | 0.99% | +61.4% |
| Q1 2016 | $3,483,000 | -16.1% | 48,094 | -0.3% | 0.61% | -21.7% |
| Q4 2015 | $4,151,000 | -7.3% | 48,247 | -1.0% | 0.78% | -10.2% |
| Q3 2015 | $4,480,000 | -41.5% | 48,744 | -37.4% | 0.87% | -39.1% |
| Q2 2015 | $7,657,000 | -1.2% | 77,867 | -1.0% | 1.43% | -0.3% |
| Q1 2015 | $7,753,000 | +4.4% | 78,620 | -1.9% | 1.43% | +2.1% |
| Q4 2014 | $7,425,000 | -2.5% | 80,138 | -1.0% | 1.40% | -11.0% |
| Q3 2014 | $7,616,000 | +3.0% | 80,918 | -0.9% | 1.58% | +2.4% |
| Q2 2014 | $7,392,000 | +5.2% | 81,651 | -1.2% | 1.54% | -11.0% |
| Q1 2014 | $7,029,000 | +4.7% | 82,676 | -1.0% | 1.73% | +7.1% |
| Q4 2013 | $6,713,000 | +2.1% | 83,512 | -2.5% | 1.61% | -9.9% |
| Q3 2013 | $6,573,000 | +7.1% | 85,692 | -1.2% | 1.79% | -14.0% |
| Q2 2013 | $6,135,000 | – | 86,763 | – | 2.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |